Published: 31 May 2023
Summary
As their industry shifts toward personalization, LSOs need to craft customized engagement experiences that can help them retain HCP’s mind share. This research helps LSO strategy leaders capitalize on this momentum and help deliver customer experiences that HCPs demand.
Included in Full Research
Overview
Key Findings
The COVID-19 pandemic has accelerated life science manufacturers’ shift toward — and healthcare providers’ (HCPs’) demand for — digital engagement in place of face-to-face interactions. Less than one-third of HCPs want the same number of face-to-face sales engagements they did pre-COVID-19.
The ever-increasing demands on HCPs’ time and attention means they’re tuning out life science organizations’ (LSOs’) sales and marketing messages — at a time when new product launches are accelerating and the need for accurate information is greater than ever.
Customer experience (CX) personalization uses customer feedback, analytics and insights to optimize interactions across touchpoints. CX improvement is one
To view the entire document, log
in or purchase
Analysts:
Corporate Strategy Research Team